ARA290 (Cibinetide)
Price range: $116.00 through $152.00
Specifications: 10 mg / 16 mg
Ingredient: ARA-290 (Cibinetide)
Dosage Form: Lyophilized Powder
Purity: >99%
Description
ARA290, also known as cibinetide, is a specialized 11-amino-acid peptide derived from the structure of erythropoietin (EPO). Unlike EPO, ARA290 does not stimulate erythropoiesis. Instead, it selectively activates the innate repair receptor (IRR), whose expression is upregulated during tissue injury and inflammatory stress. ARA290 mainly inhibits the production of pro-inflammatory cytokines and activates cellular pathways that facilitate tissue repair, cell survival and regeneration. Therefore, it serves as a highly specialized research tool for chronic inflammation and neuropathic pain.
Scientific studies on ARA290 primarily focus on its therapeutic potential for small fiber neuropathy and other disorders characterized by persistent nerve damage and localized pain. By activating the body’s intrinsic repair mechanisms, it helps stabilize nerve fibers and ameliorate the inflammatory microenvironment that triggers aberrant pain signals. Additionally, research has explored its organ-protective effects, particularly in shielding the heart, kidneys and pancreas from chronic inflammation and ischemic injury. As a targeted anti-inflammatory and cytoprotective agent, ARA290 offers a distinct therapeutic approach for complex autoimmune and neuroinflammatory diseases, without causing hematological complications associated with conventional EPO therapy.
Shipping and Delivery
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
